Document is current
Any future updates will be listed below
-
Authors
McCutcheon, Robert A. http://orcid.org/0000-0003-1102-2566
Pillinger, Toby
Guo, Xin
Rogdaki, Maria
Welby, George
Vano, Luke
Cummings, Connor http://orcid.org/0000-0002-9940-0092
Heron, Toni-Ann http://orcid.org/0000-0001-8305-6939
Brugger, Stefan http://orcid.org/0000-0002-2608-8173
Davies, David
Ghanem, Mawada
Efthimiou, Orestis
Cipriani, Andrea http://orcid.org/0000-0001-5179-8321
Howes, Oliver D.
- License Information
-
More Information
Article History
Received: 13 May 2022
Accepted: 13 December 2022
First Online: 19 January 2023
Change Date: 26 May 2023
Change Type: Update
Change Details: In the version of this article initially published, the name of Toni-Ann Heron appeared as Toni Ann-Heron; the error has been corrected in the HTML and PDF versions of the article.
Competing interests
: R.A.M. has received honoraria from Otsuka and Janssen for educational talks. A.C. has received research and consultancy fees from INCiPiT (Italian Network for Paediatric Trials) and CARIPLO Foundation and Angelini Pharma, outside the submitted work. T.P. has participated in speaker meetings organized by Sunovion, Lundbeck, Janssen and Otsuka. O.D.H. is a part-time employee of H. Lundbeck A/S and has received investigator-initiated research funding from and/or participated in advisory/speaker meetings organized by Angellini, Autifony, Biogen, Boehringer-Ingelheim, Eli Lilly, Heptares, Global Medical Education, In-vicro, Jansenn, Lundbeck, Neurocrine, Otsuka, Sunovion, Rand, Recordati, Roche and Viatris/Mylan. The remaining authors declare no competing interests.
